{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:14:36Z","timestamp":1781759676936,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":5579,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1093\/jn\/137.11.2572s","type":"journal-article","created":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T07:43:03Z","timestamp":1516174983000},"page":"2572S-2575S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Inulin and Oligofructose in Chronic Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"137","author":[{"given":"Celine H.M.","family":"Leenen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levinus A.","family":"Dieleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/jn\/137.11.2572S_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-8553(01)00002-4","article-title":"Epidemiology of inflammatory bowel disease","volume":"31","author":"Loftus","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1093\/jn\/137.11.2572S_bib2","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jama.1932.02740680019005","article-title":"Regional enteritis. A pathological and clinical entity","volume":"99","author":"Crohn","year":"1932","journal-title":"JAMA"},{"key":"10.1093\/jn\/137.11.2572S_bib3","first-page":"CD000545","article-title":"Azathioprine or 6-mercaptopurine for inducing remission of Crohn\u2019s disease","volume":"2","author":"Sandborn","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/jn\/137.11.2572S_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/gut.48.5.591","article-title":"Rational dosing of azathioprine and 6-mercaptopurine","volume":"48","author":"Sandborn","year":"2001","journal-title":"Gut"},{"key":"10.1093\/jn\/137.11.2572S_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199502023320503","article-title":"Methotrexate for the treatment of Crohn\u2019s disease","volume":"332","author":"Feagan","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1093\/jn\/137.11.2572S_bib6","first-page":"264","article-title":"The morbid appearance of the intestine of Miss Banks","volume":"2","author":"Wilks","year":"1859","journal-title":"Med Times Gazette"},{"key":"10.1093\/jn\/137.11.2572S_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1093\/jn\/137.11.2572S_bib8","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/jn\/137.11.2572S_bib9","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1093\/jn\/137.11.2572S_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00001574-200307000-00006","article-title":"Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when","volume":"19","author":"Sartor","year":"2003","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1093\/jn\/137.11.2572S_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/jn\/137.11.2572S_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D\u2019Haens","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1093\/jn\/137.11.2572S_bib13","article-title":"Enteric bacteria in chronic intestinal inflammation: role in pathogenesis and therapeutic targets","volume":"125","author":"Sartor","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1093\/jn\/137.11.2572S_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human \u03b22m: An animal model of HLA-B27-associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"key":"10.1093\/jn\/137.11.2572S_bib15","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1084\/jem.180.6.2359","article-title":"The germfree state prevents the development of gut and joint inflammatory disease in HLA-B27 transgenic rats","volume":"180","author":"Taurog","year":"1994","journal-title":"J Exp Med"},{"key":"10.1093\/jn\/137.11.2572S_bib16","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1128\/IAI.66.11.5224-5231.1998","article-title":"Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice","volume":"66","author":"Sellon","year":"1998","journal-title":"Infect Immun"},{"key":"10.1093\/jn\/137.11.2572S_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0016-5085(99)70127-7","article-title":"Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats","volume":"116","author":"Rath","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1093\/jn\/137.11.2572S_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1572-0241.2002.05613.x","article-title":"Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn\u2019s disease","volume":"97","author":"Neut","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/jn\/137.11.2572S_bib19","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1128\/IAI.67.6.2969-2974.1999","article-title":"Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli","volume":"67","author":"Rath","year":"1999","journal-title":"Infect Immun"},{"key":"10.1093\/jn\/137.11.2572S_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1099\/00222615-35-4-238","article-title":"The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique","volume":"35","author":"Giaffer","year":"1991","journal-title":"J Med Microbiol"},{"key":"10.1093\/jn\/137.11.2572S_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gut.52.2.237","article-title":"Alterations of the dominant faecal bacterial groups in patients with Crohn\u2019s disease of the colon","volume":"52","author":"Seksik","year":"2003","journal-title":"Gut"},{"key":"10.1093\/jn\/137.11.2572S_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/gast.2000.9370","article-title":"Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial","volume":"119","author":"Gionchetti","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1093\/jn\/137.11.2572S_bib23","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2005.41794.x","article-title":"VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis","volume":"100","author":"Bibiloni","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/jn\/137.11.2572S_bib24","first-page":"44","article-title":"Probiotic therapy of intestinal inflammation and infections","volume":"21","author":"Sartor","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1093\/jn\/137.11.2572S_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.52.3.370","article-title":"Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment","volume":"52","author":"Dieleman","year":"2003","journal-title":"Gut"},{"key":"10.1093\/jn\/137.11.2572S_bib26","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2174\/1389557043403369","article-title":"Cellular and physiological effects of probiotics and prebiotics","volume":"4","author":"Marteau","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"10.1093\/jn\/137.11.2572S_bib27","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/jn\/125.6.1401","article-title":"Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics","volume":"125","author":"Gibson","year":"1995","journal-title":"J Nutr"},{"key":"10.1093\/jn\/137.11.2572S_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jn\/128.1.11","article-title":"The bifidogenic nature of chicory inulin and its hydrolysis products","volume":"128","author":"Roberfroid","year":"1998","journal-title":"J Nutr"},{"key":"10.1093\/jn\/137.11.2572S_bib29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.MIB.0000183421.02316.d5","article-title":"Reduction of colitis in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation","volume":"11","author":"Hoentjen","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1093\/jn\/137.11.2572S_bib30","first-page":"581","article-title":"Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats","volume":"11","author":"Schultz","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1093\/jn\/137.11.2572S_bib31","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0016-5085(99)70013-2","article-title":"Lactobacillus sp prevents development of enterocolitis in interleukin-10 gene deficient mice","volume":"116","author":"Madsen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1093\/jn\/137.11.2572S_bib32","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1572-0241.2001.03802.x","article-title":"Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat","volume":"96","author":"Videla","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1093\/jn\/137.11.2572S_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clnu.2005.11.004","article-title":"Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis","volume":"25","author":"Lara-Villoslada","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1093\/jn\/137.11.2572S_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jn\/136.3.672","article-title":"Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis","volume":"136","author":"Daddaoua","year":"2006","journal-title":"J Nutr"},{"key":"10.1093\/jn\/137.11.2572S_bib35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1079\/BJN2003867","article-title":"Restoration of the integrity of rat caeco-colonic mucosa by resistant starch, but not by fructo-oligosaccharides, in dextran sulfate sodium-induced experimental colitis","volume":"90","author":"Moreau","year":"2003","journal-title":"Br J Nutr"},{"key":"10.1093\/jn\/137.11.2572S_bib36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1080\/003655202320378239","article-title":"Galacto-oligosaccharides stimulate the growth of bifidobacteria but fail to attenuate inflammation in experimental colitis in rats","volume":"37","author":"Holma","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1093\/jn\/137.11.2572S_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10350-004-6257-2","article-title":"Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis","volume":"45","author":"Welters","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1093\/jn\/137.11.2572S_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/gut.2004.044834","article-title":"Synbiotic therapy (Bifidobacterium longum\/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial","volume":"54","author":"Furrie","year":"2005","journal-title":"Gut"},{"key":"10.1093\/jn\/137.11.2572S_bib39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gut.2005.074971","article-title":"Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn\u2019s disease","volume":"55","author":"Lindsay","year":"2006","journal-title":"Gut"}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622094512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022316622094512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/jn\/article-pdf\/137\/11\/2572S\/23902271\/2572s.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T20:22:50Z","timestamp":1686601370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022316622094512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0022316622094512"],"URL":"https:\/\/doi.org\/10.1093\/jn\/137.11.2572s","relation":{},"ISSN":["0022-3166"],"issn-type":[{"value":"0022-3166","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inulin and Oligofructose in Chronic Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/jn\/137.11.2572S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}